Skip to main content
. 2024 Nov 15;24:811. doi: 10.1186/s12888-024-06288-9

Table 1.

Demographic and clinical data of patients with schizophrenia and healthy controls

Patients (n = 72) HC (n = 68) t/χ2/Z P
Age (years) 40.40 ± 9.53 40.38 ± 9.50 0.013 a 0.990
Education (years) 9 (6, 9) 9 (6, 12) -1.665 b 0.096
BMI (kg/m2) 24.85 ± 3.57 25.38 ± 2.80 -0.990 a 0.324
Smoking (n, %) 35 (48.6) 27 (39.7) 1.124 c 0.289
Age of onset (years) 26.65 ± 8.29 d - - -
Duration of illness (years) 12.79 ± 8.19 d - - -
Equivalent dose of chlorpromazine (mg/d) 577.73 ± 186.23 d - - -
PANSS total score 57.57 ± 15.19 d - - -
P subscores 11.18 ± 4.69 d - - -
N subscores 28.96 ± 6.15 d - - -
G subscores 17.61 ± 7.05 d - - -
RBANS total score 58.60 ± 11.13 88.32 ± 11.85 -15.306 a < 0.001
Attention 82.13 ± 13.78 106.54 ± 14.82 -10.102 a < 0.001
Language 72.07 ± 14.04 96.43 ± 11.61 -11.150 a < 0.001
Visuospatial/constructional 70.10 ± 14.70 88.63 ± 14.26 -7.565 a < 0.001
Immediate memory 50.81 ± 17.38 83.22 ± 16.97 -11.157 a < 0.001
Delay memory 54.35 ± 16.38 83.71 ± 17.54 -10.240 a < 0.001